بيوغليتازون (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "بيوغليتازون" in Arabic language version.

refsWebsite

Global rank Arabic rank

9nih.gov

4^th place

6^th place

4wikidata.org

43^rd place

2^nd place

3web.archive.org

1^st place

2ebi.ac.uk

5,849^th place

872^nd place

2fda.gov

447^th place

393^rd place

1chemspider.com

8,573^rd place

3,029^th place

1lefigaro.fr

113^th place

605^th place

1archive.today

14^th place

41^st place

1medical-reference.net

low place

archive.today

http://www.lefigaro.fr/flash-actu/2011/06/09/97001-20110609FILWWW00505-info-le-figaro-lantidiabetique-actos-retire-du-marche.php. نسخة محفوظة 2012-08-03 at Archive.is

chemspider.com

Pioglitazone، QID:Q2311683

ebi.ac.uk

fda.gov

12. Jump up^ http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm | FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer|. نسخة محفوظة 2019-04-24 على موقع واي باك مشين.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm315951.htm FDA approves first generic Actos to treat type 2 diabetes نسخة محفوظة 2016-12-18 على موقع واي باك مشين.

lefigaro.fr

http://www.lefigaro.fr/flash-actu/2011/06/09/97001-20110609FILWWW00505-info-le-figaro-lantidiabetique-actos-retire-du-marche.php. نسخة محفوظة 2012-08-03 at Archive.is

medical-reference.net

10. Jump up^ http://www.medical-reference.net/2011/12/france-and-germany-suspended-use-of.html | France and Germany Suspended Use of Actos for Bladder Cancer Risk| نسخة محفوظة 2021-01-31 على موقع واي باك مشين.

nih.gov

ncbi.nlm.nih.gov

Scheen, AJ (November 2012). "Outcomes and lessons from the PROactive study.". Diabetes research and clinical practice 98 (2): 175–86.doi:10.1016/j.diabres.2012.09.001. ببمد: 23020930.
Belfort, R; Harrison, SA; Brown, K; Darland, C; Finch, J; Hardies, J; Balas, B; Gastaldelli, A et al. (November 2006). "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis". N. Engl. J. Med. 355(22): 2297–307. doi:10.1056/NEJMoa060326. ببمد: 17135584.
Lincoff AM, Wolski K, Nicholls SJ, Nissen SE (2007). "Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials". JAMA 298 (10): 1180–8.doi:10.1001/jama.298.10.1180. ببمد: 17848652.
Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelliere R et al. (2008). "Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes".JAMA 299 (13): 1561–73. doi:10.1001/jama.299.13.1561.ببمد: 18378631.
Gillies, PS; Dunn, CJ (August 2000). "Pioglitazone". Drugs 60 (2): 333–43; discussion 344–5. doi:10.2165/00003495-200060020-00009.ببمد: 10983737.
Smith U (September 2001). "Pioglitazone: mechanism of action". Int J Clin Pract Suppl (121): 13–8. ببمد: 11594239.
Colca, JR; McDonald, WG; Waldon, DJ; Leone, JW; Lull, JM; Bannow, CA; Lund, ET; Mathews, WR (February 2004). "Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe" (PDF). Am. J. Physiol. Endocrinol. Metab. 286(2): E252–60. doi:10.1152/ajpendo.00424.2003. ببمد: 14570702.
Paddock, ML; Wiley, SE; Axelrod, HL; Cohen, AE; Roy, M; Abresch, EC; Capraro, D; Murphy, AN et al. (September 2007). "MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone". Proc. Natl. Acad. Sci. U.S.A. 104 (36): 14342–7.doi:10.1073/pnas.0707189104. PMC 1963346. ببمد: 17766440.

pubchem.ncbi.nlm.nih.gov

Pioglitazone (بالإنجليزية), QID:Q278487

web.archive.org

10. Jump up^ http://www.medical-reference.net/2011/12/france-and-germany-suspended-use-of.html | France and Germany Suspended Use of Actos for Bladder Cancer Risk| نسخة محفوظة 2021-01-31 على موقع واي باك مشين.
12. Jump up^ http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm | FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer|. نسخة محفوظة 2019-04-24 على موقع واي باك مشين.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm315951.htm FDA approves first generic Actos to treat type 2 diabetes نسخة محفوظة 2016-12-18 على موقع واي باك مشين.

wikidata.org

Pioglitazone، QID:Q2311683
pioglitazone، معهد المعلوماتية الحيوية الأوروبي، QID:Q902623
PIOGLITAZONE، QID:Q6120337
Pioglitazone (بالإنجليزية), QID:Q278487